Back
ESC Premium Access

Thirty-day and long-term outcomes after transcatheter aortic valve implantation from first-in-man to nowadays: 15 years experience of a pioneered center.

Session: TAVI: a new standard for aortic valve replacement?
Topic: Aortic valve disease
Speaker: Professor E. Durand (Rouen, FR)
Event: ESC Congress 2017

Congress Presentation

0

About the speaker

Professor Eric Durand

University Hospital of Rouen, Rouen (France)
1 presentation
0 follower

4 more presentations in this session

State of the Art: TAVI indications and adoption: a dynamic field

Speaker: Professor B. Prendergast (London, GB)

Access
Video
0
Thumbnail

Worse outcome of patients with normal ejection fraction but low-gradient aortic valve stenosis after transcatheter aortic valve implantation (TAVI)

Speaker: Doctor U. Fischer-Rasokat (Bad Nauheim, DE)

Access
Abstract
0
Thumbnail

Natural history and prognostic significance of pulmonary hypertension in patients undergoing TAVR for severe aortic stenosis

Speaker: Doctor B. Alushi (Albstadt, DE)

Access
Abstract
Slides
Video
0
Thumbnail

TAVI complications: incidence, trends and management.

Speaker: Doctor A. Chieffo (Milan, IT)

Access
Slides
Video
0
Thumbnail

Access the full session

TAVI: a new standard for aortic valve replacement?

Speakers: Professor E. Durand, Professor B. Prendergast, Doctor U. Fischer-Rasokat, Doctor B. Alushi, Doctor A. Chieffo
Access
0
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk